Pharma Mar SA (PHMMF)
72.54
0.00 (0.00%)
USD |
OTCM |
Nov 17, 16:00
Pharma Mar Price : 72.54 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 72.54 | 72.54 | 72.54 | 72.54 | 0.000 |
| Nov 16, 2026 | 72.54 | 72.54 | 72.54 | 72.54 | 100.00 |
| Nov 13, 2026 | 75.05 | 75.05 | 75.05 | 75.05 | 0.000 |
| Nov 12, 2026 | 75.05 | 75.05 | 75.05 | 75.05 | 0.000 |
| Nov 11, 2026 | 75.05 | 75.05 | 75.05 | 75.05 | 0.000 |
| Nov 10, 2026 | 75.05 | 75.05 | 75.05 | 75.05 | 0.000 |
| Nov 09, 2026 | 75.05 | 75.05 | 75.05 | 75.05 | 100.00 |
| Nov 06, 2026 | 73.89 | 73.89 | 73.89 | 73.89 | 0.000 |
| Nov 05, 2026 | 73.89 | 73.89 | 73.89 | 73.89 | 234.00 |
| Nov 04, 2026 | 70.70 | 70.70 | 70.70 | 70.70 | 0.000 |
| Nov 03, 2026 | 70.70 | 70.70 | 70.70 | 70.70 | 250.00 |
| Nov 02, 2026 | 77.09 | 77.09 | 77.09 | 77.09 | 0.000 |
| Oct 30, 2026 | 77.09 | 77.09 | 77.09 | 77.09 | 0.000 |
| Oct 29, 2026 | 77.09 | 77.09 | 77.09 | 77.09 | 360.00 |
| Oct 28, 2026 | 77.74 | 77.74 | 77.74 | 77.74 | 100.00 |
| Oct 27, 2026 | 94.60 | 94.60 | 94.60 | 94.60 | 0.000 |
| Oct 26, 2026 | 94.60 | 94.60 | 94.60 | 94.60 | 50.00 |
| Oct 23, 2026 | 94.60 | 94.60 | 94.60 | 94.60 | 20.00 |
| Oct 22, 2026 | 94.60 | 94.60 | 94.60 | 94.60 | 0.000 |
| Oct 21, 2026 | 94.60 | 94.60 | 94.60 | 94.60 | 0.000 |
| Oct 20, 2026 | 94.60 | 94.60 | 94.60 | 94.60 | 0.000 |
| Oct 19, 2026 | 94.60 | 94.60 | 94.60 | 94.60 | 0.000 |
| Oct 16, 2026 | 94.60 | 94.60 | 94.60 | 94.60 | 0.000 |
| Oct 15, 2026 | 94.60 | 94.60 | 94.60 | 94.60 | 0.000 |
| Oct 14, 2026 | 94.60 | 94.60 | 94.60 | 94.60 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Oryzon Genomics SA | 3.098 |
| Grifols SA | 8.60 |
| ACADIA Pharmaceuticals, Inc. | 18.42 |
| Alkermes Plc | 46.51 |
| Alnylam Pharmaceuticals, Inc. | 156.00 |
Price Related Metrics
| PE Ratio | 15.92 |
| PS Ratio | 4.570 |
| PEG Ratio | 0.1397 |
| Price to Book Value | 4.671 |
| Price to Free Cash Flow | 24.51 |
| Earnings Yield | 6.28% |
| Market Cap | 1.258B |
| PEGY Ratio | 0.1378 |
| Operating PE Ratio | 24.46 |
| Normalized PE Ratio | 15.92 |